Format

Send to

Choose Destination
Eur Respir J. 2017 May 19;49(5). pii: 1602566. doi: 10.1183/13993003.02566-2016. Print 2017 May.

Antacid use and subclinical interstitial lung disease: the MESA study.

Author information

1
Dept of Medicine, Columbia University Medical Center, New York, NY, USA.
2
Dept of Medicine and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
3
Dept of Medicine, University of Washington, Seattle, WA, USA.
4
Dept of Epidemiology, Columbia University Medical Center, New York, NY, USA.
5
Dept of Medicine, Columbia University Medical Center, New York, NY, USA davidlederer@columbia.edu.
PMID:
28526800
PMCID:
PMC5532532
DOI:
10.1183/13993003.02566-2016
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center